Eledon Pharmaceuticals Stock Quote ELDN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.45

Bid

2.45

Ask

2.48

Volume

364,811

2.23 Day's Range 2.4806

0.00 52 Week Range 0.00

Market Cap

59.285M

Previous Close

2.26

Open

2.23

Last Trade

2.4689

Last Trade Time

15:38:12

Financial Volume

$ 864,640

VWAP

2.3701

Average Volume (3m)

Shares Outstanding

24,198,130

Dividend Yield

PE Ratio

-1.47

Earnings Per Share (EPS)

-1.67

Revenue

Net Profit

-40.33M

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eledon.com

Headquarters

Dover, Delaware, USA

Founded

1970

Eledon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELDN. The last closing price for Eledon Pharmaceuticals was $2.26. Over the last year, Eledon Pharmaceuticals shares have traded in a share price range of $ 0.00 to $ 0.00.

Eledon Pharmaceuticals currently has 24,198,130 shares outstanding. The market capitalization of Eledon Pharmaceuticals is $59.29 million. Eledon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.47.

Form 8-K - Current report

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes Company...

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement

IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it has entered into a securities purchase agreement with certain...

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney rejection Tegoprubart used as a component of the immunosuppressive treatment regimen following...

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

IRVINE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the enrollment of the 12th participant on March 23, 2024, in the...

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Historic kidney xenotransplantation procedure conducted at Massachusetts General Hospital Tegoprubart administration has now been used investigationally to prevent rejection in both kidney and...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
REBNReborn Coffee Inc	$ 2.8799 (66.47%)	108.22M
SGDSafe and Green Development Corporation	$ 0.615 (57.53%)	67.89M
INODInnodata Inc	$ 10.2201 (51.30%)	17.84M
CRCTCricut Inc	$ 8.02 (45.03%)	7.14M
ISUNiSun Inc	$ 0.1841 (39.47%)	129.53M
TMCITreace Medical Concepts Inc	$ 4.025 (-63.80%)	11.68M
MCRBSeres Therapeutics Inc	$ 0.74465 (-32.91%)	14.47M
TOIIWOncology Institute Inc	$ 0.1168 (-32.09%)	122.56k
TRIPTripAdvisor Inc	$ 17.89 (-29.79%)	25.05M
DHDefinitive Healthcare Corporation	$ 5.255 (-27.52%)	4.21M
ISUNiSun Inc	$ 0.1841 (39.47%)	129.53M
REBNReborn Coffee Inc	$ 2.8799 (66.47%)	108.22M
SQQQProShares UltraPro Short QQQ	$ 10.7331 (0.12%)	91.08M
NKLANikola Corporation	$ 0.5797 (-3.85%)	80.37M
PEGYPineapple Energy Inc	$ 0.0704 (-7.00%)	77.79M